On August 4, Metanotitia Inc. and Thermo Fisher Scientific Inc.  jointly signed a strategic partnership agreement. The two companies will deepen technological collaboration and drive innovation in the field of "Digital Health Innovation and Application." Dr. Yan Li, CEO of Metanotitia Inc., and Ms. Liu Xueyan, Senior Business Director for Chromatography and Mass Spectrometry in Thermo Fisher's China Division, attended the signing ceremony.

Metanotitia is a company committed to the local optimization and development of cutting-edge metabolomics technology. By establishing a Chinese population-based metabolomics database and a diverse biological sample database, Metanotitia integrates life sciences with artificial intelligence technology to create a "digital life" system. The company aims to creatively apply biological data across various fields, including healthcare, agriculture, ecology, and more, addressing issues related to agriculture and food, environmental health, personal health, and disease diagnosis.

Thermo Fisher is a leader in the scientific instruments field, dedicated to accelerating research in the life sciences, addressing challenges in analytical fields, and enhancing laboratory productivity. Through this collaboration, both companies seek to leverage their complementary strengths to drive innovation and application in digital health.